BRIEF

on Zomedica Corp. (NASDAQ:ZOM)

Zomedica Names Scott A. Jordan as New CFO

Stock price chart of Zomedica Corp. (EBR:ZOM) showing fluctuations.

Zomedica Corp., specializing in veterinary health, announced that Scott A. Jordan will assume the role of Executive Vice President, Finance and Chief Financial Officer, effective January 1, 2025. Bringing over 30 years of experience in life sciences and diagnostics, Jordan's move aligns with Zomedica's strategic goals.

Jordan's background includes founding S. Jordan Associates, where he facilitated capital raising and strategic partnerships. He previously held CFO roles at biotechnology firms in Texas, contributing to significant corporate milestones, including Salarius Pharmaceuticals' NASDAQ listing. Jordan's expertise is expected to support Zomedica's growth in the animal health sector.

A Michigan State graduate with an MBA from DePaul University, Jordan succeeds Peter Donato. He aims to leverage his experience to enhance shareholder value and expand Zomedica's market impact.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Zomedica Corp. news